ArticlePharmacology research & perspectives2021

Sofosbuvir-based therapies in genotype 2 hepatitis C virus cirrhosis: A real-life experience with focus on ribavirin dose.

Carlo Smirne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.